Table 2

Contents of Bcl-xl and Bcl-xs/l protein in different types of endometrial tissue and correlation with pathological parameters of the endometrial carcinoma

Classification

Bcl-xl protein expression

Bcl-xs/l protein expression

χ ± S

P value

χ ± S

P value

Normal endometrium

41.00 ± 21.05

105.60 ± 33.05

Simple hyperplasia

49.00 ± 11.36

0.57

96.00 ± 50.48

0.75

Atypical hyperplasia

49.00 ± 11.36

0.56

73.00 ± 4.47

0.04

Endometrial carcinoma

90.88 ± 48.33

0.04

54.50 ± 18.49

0.00

Degree of Pathological Differentiation

Well-differentiated

109.29 ± 39.06

57.71 ± 22.33

Moderately-differentiated

71.50 ± 13.53

F = 4.65

56.50 ± 17.81

F = 0.32

Poorly-differentiated

56.67 ± 17.21

P = 0.03

46.67 ± 4.04

P = 0.74

Clinical Staging

Stage I

85.17 ± 50.83

61.17 ± 16.03

Stage II

108.00 ± 48.08

F = 0.30

45.50 ± 2.12

F = 4.02

Stage III

108.00 ± 52.33

P = 0.74

30.50 ± 6.36

P = 0.04

Lymph Node Metastasis

No

88.43 ± 49.33

F = 0.06

55.43 ± 21.58

F = 0.95

Yes

108.00 ± 52.33

P = 0.61

30.00 ± 5.66

P = 0.02

Depth of Myometrial Invasion

0

76.80 ± 18.78

65.60 ± 19.92

≤ 1/2

86.00 ± 38.58

F = 1.13

52.25 ± 18.55

F = 1.34

> 1/2

127.33 ± 94.99

P = 0.35

46.67 ± 2.52

P = 0.30

Ma et al. Journal of Experimental & Clinical Cancer Research 2010 29:14   doi:10.1186/1756-9966-29-14